What we have achieved

2000Volunteers recruited
250Completed trials since 1996
70Investigator Initiated Trials completed
180Industry Sponsored Trials completed

Ongoing clinical trials in IMU

Phase 2 Autism study to assess long-term efficacy of Intranasal Oxytocin and the underlying neural mechanisms

Intranasal Oxytocin for Autism Spectrum Disorder: assessing long-term efficacy and underlying neural mechanisms in a randomized controlled trial

Medical device study on treatment of Benign Prostatic Hyperplasia using ProstaCare Water Electrolysis System

ProstaCare Water Electrolysis System for the Treatment of Benign Prostatic Hyperplasia

Phase 3 Anemia Study in CKD to evaluate the safety and efficacy of daprodustat compared to recombinant human erythropoietin (ASCEND-D)

A phase 3 randomized, open-label (sponsor-blind), activecontrolled, parallel-group, multi-center, event driven study in non-dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa.

Anemia Studies in CKD: Erythropoiesis via a Novel PHI Daprodustat-Non-Dialysis (ASCEND-ND)


Be a hero to others today!

Be part of a journey to discover new therapies to improve the future of healthcare.


Interested to work together with us?

Collaborate with IMU to discover better treatments for a better tomorrow.